VIDEO: NeutriSci is into Energy Tablets, THC, and Genie Bouchard!

MidasLetter Live
|

Glen Rehman, President and Director of NeutriSci International Inc. (CVE:NU) (OTCMKTS:NRXCF) (FRA:1N9), talks to James about their energy tablets sold in retail stores right now called Neuenergy. It packs the equivalent amount of Pterostilbene found in 25,000 blueberries into each tablet.  What is Pterostilbene you ask? It is the active ingredient found in Blueberries; the part that fights off infections, increases memory and provides all the anti-oxidants.  In addition to that Neuenergy has teamed up and sponsored the women’s tennis star Genie Bouchard.  Glen also talks about their entrance into the cannabis space with their up-coming CBD and THC tablets that should be out later in the year in conjunction with Canadian federal legislation of recreational cannabis.  NeutriSci’s biggest competition could be considered to be 5-hour energy which does over 1.5 Billion in annual sales internationally.

 

 

MidasLetter Live

Midas Letter LIVE!

Midas Letter LIVE is the video channel from Midas Letter Financial Group's headquarters studio in the Exchange Tower in the heart of Canada's Financial District in downtown Toronto, Ontario, where we interview the CEO's from the top emerging companies on the Canadian publicly traded company landscape. Live Streaming on Facebook...
More Info...

live@midasletter.com

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!